The company reported strong quarterly bookings of
Fiscal Third Quarter Financial Results:
Net revenue was
$10.3 million , compared to$18.3 million in the third quarter of fiscal 2025.GAAP net loss was
$(3.2) million , or$(0.10) per diluted share, compared to GAAP net loss of$(0.6) million , or$(0.02) per diluted share, in the third quarter of fiscal 2025.Non-GAAP net loss, which excludes stock-based compensation and acquisition-related adjustments, was
$(1.5) million , or$(0.05) per diluted share, compared to non-GAAP net income of$2.0 million , or$0.07 per diluted share, in the third quarter of fiscal 2025.Bookings were
$37.2 million for the quarter.Backlog as of
February 27, 2026 was$38.7 million . Effective backlog, including bookings sinceFebruary 27, 2026 , is$50.9 million .Total cash, cash equivalents and restricted cash as of
February 27, 2026 was$37.1 million , compared to$31.0 million onNovember 28, 2025 .
Fiscal First Nine Months Financial Results:
Net revenue was
$31.2 million , compared to$44.9 million in the first nine months of fiscal 2025.GAAP net loss was
$(8.5) million , or$(0.28) per diluted share, compared to GAAP net loss of$(1.0) million , or$(0.03) per diluted share, during the first nine months of fiscal 2025.Non-GAAP net loss was
$(2.6) million , or$(0.09) per diluted share, which excludes stock-based compensation, acquisition-related adjustments and restructuring charges, compared to non-GAAP net income of$4.8 million , or$0.16 per diluted share, in the first nine months of fiscal 2025.Cash used in operating activities was
$5.1 million for the first nine months of fiscal 2026.
An explanation of the use of non-GAAP financial measures and a reconciliation of Aehr's non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the accompanying tables.
"We are very pleased with the strong momentum in our business across multiple market segments, highlighted by more than
"During the quarter, we continued to make progress in growing the business and expanding our customer base in our WLBI business. For AI processors, we received a production WLBI order from our lead AI processor customer for multiple new fully automated FOX-XP WLBI systems to be used in data center training and inference applications. We have several other companies ranging from suppliers of data center-focused AI accelerator processors to Edge AI processors and CPUs that are providing us with information on their devices and roadmaps and asking about our WLBI capabilities and recommendations for burn-in of their next generation devices. There is significant interest in doing WLBI for devices that are expected to be put in advanced packages such as CoWoS that include other die such as HBM DRAM stacks, other compute AI processors, and photonic or electrical-based transceiver chipsets. Weeding out bad devices before they are packaged together with these other devices is significantly cheaper than the yield loss if these are burned in at packaged level and the entire multi-chip package is thrown away.
"Silicon photonics is a market we see significant opportunity for WLBI. We recently announced a major new customer win with our high-power FOX-XP WLBI system for devices aimed at hyperscale data center optical interconnect market. This was an initial order for multiple
"Additionally, during the quarter, we received a follow-on order from our lead silicon photonics customer for both a new high-power FOX-XP systems and an upgrade of an existing
"In PLBI, we are seeing significant forecasts from our lead hyperscale customer for our
"In addition to this major hyperscale customer, we are also engaged in new sales opportunities with multiple other hyperscale companies, AI accelerators and CPU processor companies, edge AI processor suppliers and designers, and foundries and assembly and test houses for our Sonoma PLBI systems for both reliability qualification and production burn-in needs.
"We are continuing to scale our manufacturing capacity to support anticipated customer demand. In addition to the substantial capacity we added at our
"With strong second-half bookings so far, and a strong funnel of additional orders expected this quarter, we believe we are well-positioned to exit the fiscal year ending
"As the need for performance, reliability, safety, and security in semiconductors continues to rise, burn-in is becoming increasingly important across a widening range of devices and end markets. We believe Aehr is uniquely positioned to capitalize on this trend with both proven WLBI and PLBI solutions that enable our customers to cost-effectively qualify and screen their most advanced semiconductor devices."
Financial Guidance:
Aehr is reiterating its previously provided guidance for the second half of fiscal year 2026, which began
Management Conference Call and Webcast:
About
Headquartered in
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr's future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue," or the negative of these words or other similar terms or expressions that concern Aehr's expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, future bookings, benchmark evaluations and product development from Aehr's new and existing customers; future applications and orders for the AI processors, test solutions for AI semiconductor manufacturers and the
- Financial Tables to Follow -
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
|
| Three Months Ended |
|
| Nine Months Ended |
| ||||||||||||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||
(In thousands, except per share data) |
| 2026 |
|
| 2025 |
|
| 2025 |
|
| 2026 |
|
| 2025 |
| |||||
Revenue |
| $ | 10,313 |
|
| $ | 9,884 |
|
| $ | 18,307 |
|
| $ | 31,166 |
|
| $ | 44,879 |
|
Cost of revenue |
|
| 6,945 |
|
|
| 7,339 |
|
|
| 11,124 |
|
|
| 21,534 |
|
|
| 25,218 |
|
Gross profit |
|
| 3,368 |
|
|
| 2,545 |
|
|
| 7,183 |
|
|
| 9,632 |
|
|
| 19,661 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
| 3,167 |
|
|
| 2,972 |
|
|
| 3,140 |
|
|
| 8,988 |
|
|
| 7,777 |
|
Selling, general and administrative |
|
| 4,430 |
|
|
| 4,434 |
|
|
| 5,162 |
|
|
| 13,581 |
|
|
| 14,357 |
|
Restructuring charges |
|
| - |
|
|
| (213 | ) |
|
| - |
|
|
| 6 |
|
|
| - |
|
Total operating expenses |
|
| 7,597 |
|
|
| 7,193 |
|
|
| 8,302 |
|
|
| 22,575 |
|
|
| 22,134 |
|
Loss from operations |
|
| (4,229 | ) |
|
| (4,648 | ) |
|
| (1,119 | ) |
|
| (12,943 | ) |
|
| (2,473 | ) |
Interest income, net |
|
| 240 |
|
|
| 194 |
|
|
| 270 |
|
|
| 613 |
|
|
| 1,179 |
|
Other income (expense), net |
|
| (12 | ) |
|
| 10 |
|
|
| (25 | ) |
|
| 1,049 |
|
|
| (11 | ) |
Loss before income tax benefit |
|
| (4,001 | ) |
|
| (4,444 | ) |
|
| (874 | ) |
|
| (11,281 | ) |
|
| (1,305 | ) |
Income tax benefit |
|
| (798 | ) |
|
| (1,214 | ) |
|
| (231 | ) |
|
| (2,764 | ) |
|
| (294 | ) |
Net loss |
| $ | (3,203 | ) |
| $ | (3,230 | ) |
| $ | (643 | ) |
| $ | (8,517 | ) |
| $ | (1,011 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
| $ | (0.10 | ) |
| $ | (0.11 | ) |
| $ | (0.02 | ) |
| $ | (0.28 | ) |
| $ | (0.03 | ) |
Diluted |
| $ | (0.10 | ) |
| $ | (0.11 | ) |
| $ | (0.02 | ) |
| $ | (0.28 | ) |
| $ | (0.03 | ) |
Shares used in per share calculations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
| 30,695 |
|
|
| 30,177 |
|
|
| 29,733 |
|
|
| 30,265 |
|
|
| 29,500 |
|
Diluted |
|
| 30,695 |
|
|
| 30,177 |
|
|
| 29,733 |
|
|
| 30,265 |
|
|
| 29,500 |
|
RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(Unaudited)
|
| Three Months Ended |
|
| Nine Months Ended |
| ||||||||||||||
|
|
|
|
|
|
|
|
|
|
| ||||||||||
(In thousands, except per share data) |
| 2026 |
|
| 2025 |
|
| 2025 |
|
| 2026 |
|
| 2025 |
| |||||
Reconciliation of GAAP to non-GAAP gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
GAAP gross profit |
| $ | 3,368 |
|
| $ | 2,545 |
|
| $ | 7,183 |
|
| $ | 9,632 |
|
| $ | 19,661 |
|
Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a) Stock-based compensation expense |
|
| 202 |
|
|
| 215 |
|
|
| 218 |
|
|
| 576 |
|
|
| 380 |
|
b) Acquisition-related adjustments |
|
| 190 |
|
|
| 190 |
|
|
| 416 |
|
|
| 617 |
|
|
| 1,045 |
|
Non-GAAP gross profit |
| $ | 3,760 |
|
| $ | 2,950 |
|
| $ | 7,817 |
|
| $ | 10,825 |
|
| $ | 21,086 |
|
Reconciliation of GAAP to non-GAAP operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP operating expenses |
| $ | 7,597 |
|
| $ | 7,193 |
|
| $ | 8,302 |
|
| $ | 22,575 |
|
| $ | 22,134 |
|
Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a) Stock-based compensation expense |
|
| (1,182 | ) |
|
| (1,626 | ) |
|
| (1,180 | ) |
|
| (4,320 | ) |
|
| (2,963 | ) |
b) Acquisition-related adjustments |
|
| (106 | ) |
|
| (106 | ) |
|
| (106 | ) |
|
| (317 | ) |
|
| (247 | ) |
c) Restructuring charges |
|
| - |
|
|
| 213 |
|
|
| - |
|
|
| (6 | ) |
|
| - |
|
d) Officer severance benefits |
|
| - |
|
|
| - |
|
|
| (653 | ) |
|
| - |
|
|
| (653 | ) |
e) Acquisition-related costs |
|
| - |
|
|
| - |
|
|
| (51 | ) |
|
| - |
|
|
| (548 | ) |
Non-GAAP operating expenses |
| $ | 6,309 |
|
| $ | 5,674 |
|
| $ | 6,312 |
|
| $ | 17,932 |
|
| $ | 17,723 |
|
Reconciliation of GAAP to non-GAAP income (loss) from operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP loss from operations |
| $ | (4,229 | ) |
| $ | (4,648 | ) |
| $ | (1,119 | ) |
| $ | (12,943 | ) |
| $ | (2,473 | ) |
Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a) Stock-based compensation expense |
|
| 1,384 |
|
|
| 1,841 |
|
|
| 1,398 |
|
|
| 4,896 |
|
|
| 3,343 |
|
b) Acquisition-related adjustments |
|
| 296 |
|
|
| 296 |
|
|
| 522 |
|
|
| 934 |
|
|
| 1,292 |
|
c) Restructuring charges |
|
| - |
|
|
| (213 | ) |
|
| - |
|
|
| 6 |
|
|
| - |
|
d) Officer severance benefits |
|
| - |
|
|
| - |
|
|
| 653 |
|
|
| - |
|
|
| 653 |
|
e) Acquisition-related costs |
|
| - |
|
|
| - |
|
|
| 51 |
|
|
| - |
|
|
| 548 |
|
Non-GAAP income (loss) from operations |
| $ | (2,549 | ) |
| $ | (2,724 | ) |
| $ | 1,505 |
|
| $ | (7,107 | ) |
| $ | 3,363 |
|
Reconciliation of GAAP to non-GAAP income (loss) before income tax benefit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP loss before income tax benefit |
| $ | (4,001 | ) |
| $ | (4,444 | ) |
| $ | (874 | ) |
| $ | (11,281 | ) |
| $ | (1,305 | ) |
Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a) Stock-based compensation expense |
|
| 1,384 |
|
|
| 1,841 |
|
|
| 1,398 |
|
|
| 4,896 |
|
|
| 3,343 |
|
b) Acquisition-related adjustments |
|
| 296 |
|
|
| 312 |
|
|
| 522 |
|
|
| 973 |
|
|
| 1,292 |
|
c) Restructuring charges |
|
| - |
|
|
| (213 | ) |
|
| - |
|
|
| 6 |
|
|
| - |
|
d) Officer severance benefits |
|
| - |
|
|
| - |
|
|
| 653 |
|
|
| - |
|
|
| 653 |
|
e) Acquisition-related costs |
|
| - |
|
|
| - |
|
|
| 51 |
|
|
| - |
|
|
| 548 |
|
Non-GAAP income (loss) before income tax benefit |
| $ | (2,321 | ) |
| $ | (2,504 | ) |
| $ | 1,750 |
|
| $ | (5,406 | ) |
| $ | 4,531 |
|
Reconciliation of GAAP to non-GAAP net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
| $ | (3,203 | ) |
| $ | (3,230 | ) |
| $ | (643 | ) |
| $ | (8,517 | ) |
| $ | (1,011 | ) |
Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a) Stock-based compensation expense |
|
| 1,384 |
|
|
| 1,841 |
|
|
| 1,398 |
|
|
| 4,896 |
|
|
| 3,343 |
|
b) Acquisition-related adjustments |
|
| 296 |
|
|
| 312 |
|
|
| 522 |
|
|
| 973 |
|
|
| 1,292 |
|
c) Restructuring charges |
|
| - |
|
|
| (213 | ) |
|
| - |
|
|
| 6 |
|
|
| - |
|
d) Officer severance benefits |
|
| - |
|
|
| - |
|
|
| 653 |
|
|
| - |
|
|
| 653 |
|
e) Acquisition-related costs |
|
| - |
|
|
| - |
|
|
| 51 |
|
|
| - |
|
|
| 548 |
|
Non-GAAP net income (loss) |
| $ | (1,523 | ) |
| $ | (1,290 | ) |
| $ | 1,981 |
|
| $ | (2,642 | ) |
| $ | 4,825 |
|
Reconciliation of GAAP to non-GAAP income (loss) per diluted share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP loss per diluted share |
| $ | (0.10 | ) |
| $ | (0.11 | ) |
| $ | (0.02 | ) |
| $ | (0.28 | ) |
| $ | (0.03 | ) |
Special items: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
a) Stock-based compensation expense |
|
| 0.04 |
|
|
| 0.06 |
|
|
| 0.05 |
|
|
| 0.16 |
|
|
| 0.11 |
|
b) Acquisition-related adjustments |
|
| 0.01 |
|
|
| 0.01 |
|
|
| 0.02 |
|
|
| 0.03 |
|
|
| 0.04 |
|
c) Restructuring charges |
|
| - |
|
|
| (0.01 | ) |
|
| - |
|
|
| 0.00 |
|
|
| - |
|
d) Officer severance benefits |
|
| - |
|
|
| - |
|
|
| 0.02 |
|
|
| - |
|
|
| 0.02 |
|
e) Acquisition-related costs |
|
| - |
|
|
| - |
|
|
| 0.00 |
|
|
| - |
|
|
| 0.02 |
|
Non-GAAP income (loss) per diluted share * |
| $ | (0.05 | ) |
| $ | (0.04 | ) |
| $ | 0.07 |
|
| $ | (0.09 | ) |
| $ | 0.16 |
|
a) Represents compensation expense for equity awards granted to employees and directors. |
b) Represents amortization of acquired intangible assets and accretion expense of escrow payable. |
c) Represents a net credit to restructuring charges, primarily related to a lease early termination, along with employee termination benefits from a separate restructuring initiative. |
d) Represents severance benefits, including compensation expense, provided due to the passing of an officer as per the terms of his change in control and severance agreement |
e) Represents acquisition activity costs. |
* Per share amounts may not sum due to rounding to the nearest cent per diluted share |
|
Non-GAAP measures should not be considered a replacement for GAAP results. The non-GAAP measures indicated above are financial measures the Company uses to evaluate the underlying results and operating performance of the business. The limitation of these measures are that they exclude items that impact the Company's current period GAAP measures. This limitation is best addressed by using these measures in combination with the most directly comparable GAAP financial measures. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies. |
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
|
|
|
| |||||
(In thousands, except par value) |
| 2026 |
|
| 2025 |
| ||
ASSETS |
|
|
|
|
|
| ||
Current assets: |
|
|
|
|
|
| ||
Cash and cash equivalents |
| $ | 36,911 |
|
| $ | 24,529 |
|
Accounts receivable |
|
| 11,808 |
|
|
| 14,191 |
|
Inventories |
|
| 41,162 |
|
|
| 41,997 |
|
Prepaid expenses and other current assets |
|
| 6,019 |
|
|
| 8,061 |
|
Total current assets |
|
| 95,900 |
|
|
| 88,778 |
|
Property and equipment, net |
|
| 9,277 |
|
|
| 8,969 |
|
|
| 10,719 |
|
|
| 10,719 |
| |
Intangible assets, net |
|
| 9,847 |
|
|
| 10,781 |
|
Deferred tax assets, net |
|
| 21,883 |
|
|
| 19,114 |
|
Operating lease right-of-use assets, net |
|
| 9,089 |
|
|
| 9,601 |
|
Other non-current assets |
|
| 331 |
|
|
| 546 |
|
Total assets |
| $ | 157,046 |
|
| $ | 148,508 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
| $ | 2,103 |
|
| $ | 6,728 |
|
Accrued expenses and other current liabilities |
|
| 4,176 |
|
|
| 6,020 |
|
Operating lease liabilities, short-term |
|
| 606 |
|
|
| 909 |
|
Deferred revenue, short-term |
|
| 1,857 |
|
|
| 1,981 |
|
Total current liabilities |
|
| 8,742 |
|
|
| 15,638 |
|
Operating lease liabilities, long-term |
|
| 9,419 |
|
|
| 9,921 |
|
Deferred revenue, long-term |
|
| 53 |
|
|
| 36 |
|
Other long-term liabilities |
|
| 40 |
|
|
| 42 |
|
Total liabilities |
|
| 18,254 |
|
|
| 25,637 |
|
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
|
|
Preferred stock, |
|
|
|
|
|
|
|
|
Issued and outstanding: none |
|
| - |
|
|
| - |
|
Common stock, |
|
|
|
|
|
|
|
|
Issued and outstanding: 30,954 shares and 29,877 shares at |
|
| 310 |
|
|
| 299 |
|
Additional paid-in capital |
|
| 170,143 |
|
|
| 145,758 |
|
Accumulated other comprehensive loss |
|
| (84 | ) |
|
| (126 | ) |
Accumulated deficit |
|
| (31,577 | ) |
|
| (23,060 | ) |
Total shareholders' equity |
|
| 138,792 |
|
|
| 122,871 |
|
Total liabilities and shareholders' equity |
| $ | 157,046 |
|
| $ | 148,508 |
|
CONDENSED CONSOLIDATED SATEMENTS OF CASH FLOWS
(Unaudited)
| Nine Months Ended |
| ||||||
|
|
|
| |||||
(In thousands) |
| 2026 |
|
| 2025 |
| ||
Cash flows from operating activities: |
|
|
|
|
|
| ||
Net loss |
| $ | (8,517 | ) |
| $ | (1,011 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
| 4,896 |
|
|
| 3,741 |
|
Depreciation and amortization |
|
| 2,110 |
|
|
| 1,573 |
|
Deferred income taxes |
|
| (2,769 | ) |
|
| (293 | ) |
Amortization of operating lease right-of-use assets |
|
| 543 |
|
|
| 795 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
| 2,387 |
|
|
| (962 | ) |
Inventories |
|
| 203 |
|
|
| (2,211 | ) |
Prepaid expenses and other assets |
|
| 457 |
|
|
| (4,831 | ) |
Accounts payable |
|
| (3,476 | ) |
|
| 139 |
|
Accrued expenses |
|
| (38 | ) |
|
| (515 | ) |
Deferred revenue |
|
| (108 | ) |
|
| (1,004 | ) |
Operating lease liabilities |
|
| (836 | ) |
|
| (470 | ) |
Income taxes payable |
|
| 6 |
|
|
| (49 | ) |
Net cash used in operating activities |
|
| (5,142 | ) |
|
| (5,098 | ) |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
| (1,932 | ) |
|
| (2,174 | ) |
Payments for business acquisition, net of cash and cash equivalents acquired |
|
| (1,801 | ) |
|
| (11,075 | ) |
Net cash used in investing activities |
|
| (3,733 | ) |
|
| (13,249 | ) |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock from public offering, net of issuance costs |
|
| 19,595 |
|
|
| - |
|
Proceeds from issuance of common stock under employee plans |
|
| 1,125 |
|
|
| 894 |
|
Shares repurchased for tax withholdings on vesting of restricted stock units |
|
| (1,273 | ) |
|
| (520 | ) |
Net cash provided by financing activities |
|
| 19,447 |
|
|
| 374 |
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
| 9 |
|
|
| 25 |
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
|
| 10,581 |
|
|
| (17,948 | ) |
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and restricted cash, beginning of period(1) |
|
| 26,480 |
|
|
| 49,309 |
|
Cash, cash equivalents and restricted cash, end of period (1) |
| $ | 37,061 |
|
| $ | 31,361 |
|
|
|
|
|
|
|
|
|
|
(1) Includes restricted cash within prepaid expenses and other current assets and other non-current assets. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contacts:
|
|
|
SOURCE:
View the original press release on ACCESS Newswire